Advertisement

Reactions Weekly

, Volume 1765, Issue 1, pp 24–24 | Cite as

Alteplase/dabigatran-etexilate/idarucizumab

Lack of efficacy following concomitant administration of idarucizumab and alteplase and second stroke due to hyper-coagulative effect of dabigatran-etexilate: case report
Case report
  • 17 Downloads

Reference

  1. Simaan N. First case in israel of intravenous thrombolysis with tissue plasminogen activator (TPA) in acute ischemic stroke after dabigatran reversal with idarucizumab. European Stroke Journal 4 (Suppl. 1): 722, May 2019. Available from: URL: http://doi.org/10.1177/2396987319845581 [abstract] -Israel

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations